Prevent Vitamin K2 Deficiency and Reduce the Risk of having Cardiovascular Disease [Interview][Transcript]

Dr_Hogne_Vik_vitamin_K2Guest: Dr. Hogne Vik
Presenter: Henry Acosta
Guest Bio: Dr. Hogne Vik is Chief Medical Officer at NattoPharma ASA, Chairman at Bransjeradet For Naturmidler, Chairman at NMIF and Chairman at Stiftelsen Norsk Matkultur. He is on the Board of Directors at Gastronomisk Institutt AS and VitaSynth Ltd. Dr. Vik was previously employed as Chief Executive Officer by ImmunoPharma AS, Senior Vice President-Medical & Regulatory Affairs by Pronova BioPharma ASA, and Chairman-Science Board by Aker Biomarine Antarctic AS.

Segment overview: In today’s Health Supplier Segment, we are joined by Norwegian doctor Dr. Hogne Vik here to will explain the vital function of vitamin K2 supported by a substantial body of clinical evidence. He will be speaking at the 5th BioCeuticals Research Symposium, which will be held from 21-23 April 2017 at the Hilton Hotel, Sydney. Doctor Vik discusses what a study recently found that vitamin K2 protects against arterial calcification and even improves arterial flexibility by helping the body properly utilise calcium. Also, he is here to provide insights on how healthcare professionals can help patients ensure their calcium is being properly utilised to build strong bones while simultaneously protecting hearts.

Health Professional Radio – Vitamin K2 Deficiency

Liked it? Take a second to support healthprofessionalradio on Patreon!
Become a patron at Patreon!